Big food versus the people: What court battles in Brazil, Colombia and Mexico reveal about the ultra-processed food industry’s corporate litigation strategies
This cross-country analysis examines 228 legal cases brought by the ultra-processed food industry against nutrition policies in Brazil, Colombia, and Mexico. While courts upheld health measures in 81% of cases, industry litigation successfully delayed implementation and strained regulatory capacity, highlighting the need for robust legal preparedness by governments.
Please login or join for free to read more.
OVERVIEW
Introduction
An unhealthy diet is a primary cause of chronic disease globally, driven by the expansion of ultra-processed foods (UPFs). In response, governments have adopted policies such as front-of-pack nutrition labelling (FOPWL), marketing restrictions, and taxes on sugary drinks. These measures often face coordinated resistance from the ultra-processed food industry. This study focuses on corporate litigation as a distinct commercial determinant of health employed to obstruct, weaken, or repeal such measures. Even when unsuccessful, legal challenges can delay implementation, impose administrative costs on the state, and discourage future policy action through regulatory chill.
Methods
Researchers conducted a systematic analysis of domestic litigation involving the ultra-processed food industry in Brazil, Colombia, and Mexico between 2010 and 2026. These countries were selected as leading jurisdictions for food policy innovation and industry contestation. The study mapped major food and nutrition laws and searched publicly accessible judicial databases for proceedings initiated at highest courts. A total of 228 cases were identified and analysed based on frequency, duration, policy area challenged, type of litigant, and judicial outcomes.
Results
The study identified 228 cases: 193 in Mexico, 18 in Colombia, and 17 in Brazil. Labelling was the most frequently disputed issue with 142 cases, followed by taxation (39 cases) and marketing restrictions (25 cases). In Mexico, litigation was dominated by direct corporate filings from transnational corporations, including the Coca-Cola System (24 cases), PepsiCo (17 cases), Mondelez (7 cases), and Danone (5 cases). Conversely, litigation in Brazil was largely led by industry associations such as ABIA and ABIR, while in Colombia, individual claimants brought most cases via public unconstitutionality actions.
Case durations varied significantly by jurisdiction. Brazil recorded a median case duration of nine years (3,295 days), primarily due to prolonged appeals regarding advertising regulations. Mexico had a median duration of 694 days, while Colombia’s median was 89 days. Regarding outcomes, the public health side (The People) prevailed in 81% of cases (183 cases), where courts upheld regulations. Industry plaintiffs (Big Food) won outright in only 3 cases (1.3%), while 11.5% of cases remained ongoing as of mid-2026. In Mexico, 11 cases were withdrawn, potentially reflecting a strategy to avoid unfavourable rulings.
Discussion
Litigation is identified as a predominantly post-adoption strategy, deployed once a measure has been enacted. The findings confirm that litigation clusters around the introduction of world-leading regulatory instruments. A “winning by losing” strategy is evident; even when industry loses on the merits, litigation achieves strategic objectives by delaying implementation, consuming regulatory capacity, and generating legal uncertainty. For example, in Brazil, repeated litigation prolonged regulatory uncertainty and delayed the consolidation of the national health regulator’s authority. The choice of litigant—whether a company, association, or proxy—is a strategic decision aimed at managing reputational risk and public perception.
Conclusion
Domestic litigation is a significant commercial determinant of health that functions to delay and constrain nutrition policy. As more countries pursue comprehensive reforms, governments must anticipate post-adoption litigation and build legal preparedness as an essential component of policy design. Practical measures include drafting regulations with attention to common legal grounds, establishing dedicated legal defence capacity within health ministries, and developing mechanisms for cross-country legal knowledge exchange. Supporting international and regional bodies can facilitate this exchange to help governments navigate industry legal pushback effectively.